Related Experiment Video
Updated: Jul 18, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
M-T5, the ankyrin repeat, host range protein of myxoma virus, activates Akt and can be functionally replaced by
Steven J Werden1, John W Barrett, Gen Wang
1Department of Microbiology and Immunology, University of Western Ontario and Robarts Research Institute, London, Ontario, Canada.
Abstract:
The myxoma virus (MV) ankyrin repeat, host range factor M-T5 has the ability to bind and activate cellular Akt, leading to permissive MV replication in a variety of diverse human cancer cell lines (G. Wang, J. W. Barrett, M. Stanford, S. J. Werden, J. B. Johnston, X. Gao, M. Sun, J. Q. Cheng, and G. McFadden, Proc. Natl. Acad. Sci. USA 103:4640-4645, 2006). The susceptibility of permissive human cancer cells to MV infection is directly correlated with the basal or induced levels of phosphorylated Akt. When M-T5 is deleted from MV, the knockout virus, vMyxT5KO, can no longer productively infect a subset of human cancer cells (designated type II) that exhibit little or no endogenous phosphorylated Akt. In searching for a host counterpart of M-T5, we noted sequence similarity of M-T5 to a recently identified ankyrin repeat cellular binding protein of Akt called PIKE-A. PIKE-A binds and activates the kinase activity of Akt in a GTP-dependent manner and promotes the invasiveness of human cancer cell lines. Here, we demonstrate that transfected PIKE-A is able to rescue the ability of vMyxT5KO to productively infect type II human cancer cells that were previously resistant to infection. Also, cancer cells that were completely nonpermissive for both wild-type and vMyxT5KO infection (called type III) were rendered fully permissive following ectopic expression of PIKE-A. We conclude that the MV M-T5 host range protein is functionally interchangeable with the host PIKE-A protein and that the activation of host Akt by either M-T5 or PIKE-A is critical for the permissiveness of human cancer cells for MV.
Insights
Myxoma virus M-T5 protein activates Akt, enabling cancer cell infection. The host protein PIKE-A can substitute for M-T5, rescuing viral replication in resistant cancer cells. This highlights Akt activation
Area of Science:
- Virology
- Molecular Biology
- Oncology
Background:
- Myxoma virus (MV) host range factor M-T5 activates cellular Akt, facilitating MV replication in human cancer cells.
- Cancer cell susceptibility to MV infection correlates with Akt phosphorylation levels.
- MV lacking M-T5 (vMyxT5KO) fails to infect certain cancer cells lacking endogenous phosphorylated Akt.
Purpose of the Study:
- To investigate the role of the host protein PIKE-A as a functional counterpart to MV M-T5.
- To determine if PIKE-A can restore MV permissiveness in resistant cancer cells.
Main Methods:
- Sequence similarity analysis identified PIKE-A as a potential Akt-binding protein.
- Transfection of PIKE-A into cancer cell lines.
- Infection assays with wild-type MV and vMyxT5KO in transfected and non-transfected cells.
Main Results:
- Transfected PIKE-A rescued vMyxT5KO replication in previously resistant type II human cancer cells.
- Ectopic PIKE-A expression rendered nonpermissive type III cancer cells fully permissive to MV infection.
- PIKE-A activates Akt kinase activity in a GTP-dependent manner and promotes cancer cell invasiveness.
Conclusions:
- The MV M-T5 protein is functionally interchangeable with the host PIKE-A protein.
- Activation of host Akt by either M-T5 or PIKE-A is critical for human cancer cell permissiveness to MV.
- This interaction provides a mechanism for targeting cancer cells with oncolytic viruses.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

